Core Insights - IBA has signed a contract with PET Pharm Bio to establish a PET and SPECT isotopes production center in Taipei, Taiwan, utilizing the Cyclone IKON cyclotron technology [1][4] - The new facility will produce novel radiopharmaceuticals for theranostics and targeted therapies, including isotopes such as Germanium-68, Iodine-123, Thallium-201, Zirconium-89, and Copper-64 [3][4] - The Cyclone IKON solution is expected to enhance PET Pharm Bio's capabilities in the radiopharmaceutical market, positioning it as a leader in Taiwan and Southeast Asia [4] Company Overview - PET Pharm Bio, established in 2011, focuses on the research, development, and production of radiopharmaceuticals, aiming to improve patient health and advance precision diagnosis and treatment in nuclear medicine [6] - IBA is recognized as the world leader in particle accelerator technology, providing equipment and services in proton therapy, industrial sterilization, and radiopharmaceuticals, with a workforce of approximately 2,100 employees [7] Financial Aspects - The typical end-user price for a Cyclone IKON solution ranges from EUR 10 million to EUR 15 million, depending on options and associated equipment [3]

Core Points - The Supervisory Board of EfTEN Real Estate Fund AS has decided to extend the term of office for the members of the Management Board for an additional 5 years until May 20, 2030 [1] Company Summary - Viljar Arakas and Tõnu Uustalu will continue as members of the Management Board [1] - The decision reflects the Supervisory Board's confidence in the current management team [1]

Core Viewpoint - Idorsia Ltd has secured a CHF 150 million new money facility to extend its cash runway to mid-2026 and has provided an update on the restructuring of its convertible bond debt, along with an upgraded financial outlook for 2025 and beyond [2][3][9]. Financial Update - The new money facility will be drawn down in the coming days and has a maturity of 24 months, fully backed by a bondholder group [3]. - The company expects net sales of around CHF 130 million for QUVIVIQ in 2025, with a projected non-GAAP operating loss of approximately CHF 175 million [16][19]. - Idorsia aims to achieve sustainable commercial profitability in 2026 and overall profitability by the end of 2027, with QUVIVIQ sales ramping up to around CHF 210 million in 2026 and CHF 270 million in 2027 [19][20]. Commercial Strategy - The company is focusing on the commercial ramp-up of QUVIVIQ, which has seen a 50% growth quarter on quarter in Q1 2025, with 10 million tablets prescribed compared to 15 million for the entire year of 2024 [6][8]. - Efforts are being made to secure reimbursement in various countries, including Spain and the Nordic region, and to expand co-promotion partnerships in the GP market [6][9]. Debt Restructuring - Approximately 90% of bondholders have agreed to amend terms and exchange bonds for newly created notes in Idorsia Investments SARL, which will help remove the convertible debt overhang [9][12]. - The restructuring will sequester rights to three of Idorsia's assets, allowing for the repayment of the newly created notes [11][13]. R&D and Pipeline - Idorsia has a strong track record in discovering first- or best-in-class drugs and is prioritizing assets in its pipeline that have the greatest potential for mid-term value creation [10]. - The company is actively working on several compounds, including QUVIVIQ, lucerastat, and others, with ongoing clinical trials and regulatory discussions [25][36][29]. Future Outlook - The company expects to achieve positive operating cash flow from 2028 onwards and plans to raise CHF 50 million via a new equity line to extend its cash runway [21]. - Idorsia is also exploring options to finance operations and repay the new money facility at maturity [21].

Core Viewpoint Wix.com Ltd. reported strong financial results for Q1 2025, highlighting significant growth in bookings and revenue, driven by product innovation and a robust user base. The launch of Wixel, an AI-powered visual design platform, marks a strategic expansion beyond website creation, aiming to democratize digital creation for users of all skill levels. Financial Performance - Q1 2025 total bookings reached $511 million, reflecting a 12% year-over-year increase, with strong demand continuing into April and early May [4][10] - Total revenue for Q1 2025 was $474 million, exceeding expectations and up 13% year-over-year, driven by growth in Self Creators and Partners segments [4][11] - Creative Subscriptions revenue was $338 million, up 11% year-over-year, while Business Solutions revenue increased by 18% to $136 million [5][25] - Free cash flow for Q1 2025 was $142 million, with a free cash flow margin of 30% [4][12] Product Innovation - The launch of Wixel represents a significant milestone for Wix, integrating advanced design tools into a single platform, aimed at enhancing user experience and accessibility [2][4] - The company continues to focus on empowering Self Creators and enhancing its AI capabilities, which have contributed to the strong performance in new user cohorts [9][10] Share Repurchase Program - Wix's Board of Directors has authorized an increase in the share repurchase program to a total of $400 million, reflecting confidence in the company's financial health [6][14] Financial Outlook - The company maintains its full-year bookings outlook of $2,025 - 2,060 million, projecting an 11-13% year-over-year increase, while also expecting total revenue for the year to be between $1,970 - 2,000 million, up 12-14% year-over-year [10][11] - For Q2 2025, Wix anticipates revenue between $485 - 489 million, representing an 11-12% year-over-year growth [11][12]

WISeKey Launches WISe.ART 3.0, One of the World’s First and Largest Web3 Marketplaces for Digital Art, Twins, NFTs, and Crypto Collectibles Geneva, Switzerland — May 21, 2025 — WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, in partnership with its subsidiary, SEALSQ Corp (Nasdaq: LAES), which focuses on semiconductors, PKI, and post-quantum technology products, today announces the launch of new enhanced WISe.ART marketpla ...

May 21, 2025 | SAINT HELIER, Jersey | CoinShares International Limited ("CoinShares'' or "the Group") (Nasdaq Stockholm: CS; US OTCQX: CNSRF), a leading global investment company specializing in digital assets with over $6 billion in AUM, announces the expansion of its Swedish XBT Provider Platform with the launch of seven new physically-backed crypto Exchange Traded Products (ETPs). CoinShares is leveraging its well-established and respected Swedish platform, CoinShares XBT Provider AB, to offer investors ...

ORION CORPORATION INVESTOR NEWS 21 MAY 2025 at 07.30 EEST Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers Orion’s collaborator, MSD, has expanded the development program for opevestostat (MK-5684) to now include women’s cancers. A new Phase 2 clinical trial evaluating the safety and efficacy of opevesostat for the treatment of breast, endometrial and ovarian cancers has been posted to ClinicalTrials.gov database. The study is not yet recruiting patients. ...

CGTN published an article on Chinese President Xi Jinping’s inspection tour of central China’s Henan Province. Focusing on the province’s efforts to boost high-quality development and enhance governance efficiency, the article highlights the Chinese president’s emphasizing that high-quality development is fundamental to advancing Chinese modernization. BEIJING, May 21, 2025 (GLOBE NEWSWIRE) -- Located in Luoyang in central China's Henan Province, Luoyang Bearing Group Co., Ltd. is a traditional manufacturin ...

Core Viewpoint - Cipher Mining Inc. has announced a public offering of $150 million in convertible senior notes due 2030, with a potential additional $22.5 million for over-allotments, aimed at financing its data center project and other corporate purposes [1][5]. Group 1: Offering Details - The notes will have a 1.75% annual interest rate, payable semi-annually, and will mature on May 15, 2030 [2]. - The initial conversion rate is set at 224.9213 shares of common stock per $1,000 principal amount of notes, equating to an initial conversion price of approximately $4.45 per share, representing a 30% premium over the concurrent public offering price of $3.42 per share [2]. - The notes can be redeemed by the company starting May 22, 2028, if the stock price exceeds 130% of the conversion price for a specified period [3]. Group 2: Use of Proceeds - The net proceeds from the offering are expected to be $145.875 million, which will be used to complete Phase 1 of the Black Pearl data center project, including purchasing mining rigs, paying tariffs, and other infrastructure-related expenditures [5]. - An amendment to the Future Sales and Purchase Agreement with Bitmain Technologies has been made to accelerate rig delivery and reduce costs by 10% [5]. Group 3: Concurrent Offering - Concurrently, Morgan Stanley will offer 17,540,000 shares of Cipher's common stock at $3.42 per share to facilitate hedging transactions related to the notes offering [6][7]. - The completion of the notes offering is contingent on the successful completion of the concurrent delta offering [7]. Group 4: Company Overview - Cipher focuses on developing and operating industrial-scale data centers for bitcoin mining and high-performance computing (HPC) hosting, aiming to be a market leader in innovation within the sector [10].

Core Insights - The 2025 China Fuzhou International Investment Promotion Month Launch Ceremony and the "Together for Prosperity in Fuzhou" Global Investment Promotion Conference took place in Fuzhou, Fujian, on May 18, 2025, co-sponsored by various governmental bodies [5][7]. Investment Opportunities - The conference facilitated communication and cooperation between Fuzhou and global enterprises, highlighting Fuzhou's strategic position in China's economic initiatives, including the 21st Century Maritime Silk Road and several national pilot zones [2][3]. - A total of 82 projects were signed during the conference, with a combined investment exceeding 130 billion yuan, indicating strong interest from investors [3]. Economic Landscape - Fuzhou is experiencing growth in its digital, marine, green, and sightseeing economies, supported by six industrial clusters valued at 100 billion yuan each, four industrial parks of the same value, and 20 enterprises valued at 10 billion yuan [2]. - The city is home to 217 industry leaders and over 4,600 national high-tech companies, showcasing its robust industrial ecosystem [2]. Event Details - The China Fuzhou International Investment Promotion Month runs from May 18 to June 18, 2025, with expectations to attract at least 10,000 participants, including activities tailored for overseas Chinese and foreign businessmen [4].